NINTEDANIB 150 mg CIPLA


Capsule
scheduling status
S4
registration number
56/26/0705.703
What NINTEDANIB 150 mg CIPLA contains
Nintedanib esylate.
other ingredients
Capsule content - Hard fat (softisan 378), Lecithin (topcithin SB PCR Negative), Medium chain triglyceride (miglyol 812 N). Capsule shell - Ferric oxide (red) (colour index number: 77491, E-number: E172), Ferric oxide (yellow) (colour index number: 77492, E-number: E172) Gelatin (gelita RXL), Glycerin, Purified water, Titanium dioxide.
Therapeutic classification
L01EX09.
© 2026 SAHPRA. ALL RIGHTS RESERVED